Publication Name	World Journal of Psychiatry
Manuscript ID	109581
Country	United States

Category	Psychiatry
Manuscript Type	Minireviews
Article Title	Agitation in Alzheimer’s disease: From assessment to therapeutics
Manuscript Source	Invited Manuscript
All Author List	Antonio L Teixeira, Youngran Kim, Thiago M Cordeiro, Gabriel A de Erausquin and Natalia P Rocha
Funding Agency and Grant Number	Funding Agency Grant Number National Institutes of Health/National Institute on Aging No. 1R21AG091282
Corresponding Author	Antonio L Teixeira, Biggs Institute, The University of Texas Health Science Center at San Antonio, 8300 Floyd Curl Drive, San Antonio, TX 78229, United States. altexr@gmail.com
Key Words	Alzheimer’s disease; Dementia; Agitation; Aggression; Antipsychotics; Antidepressants
Core Tip	In Alzheimer’s disease, agitation is a clinically relevant neuropsychiatric syndrome managed by non-pharmacological and pharmacological approaches. Ruling out delirium, identifying and addressing environmental triggers (e.g., change in caregiver) are fundamental therapeutic steps. Antipsychotics (e.g., brexpiprazole, risperidone) are commonly used in acute agitation, especially in the context of potential harm to self and others. For chronic agitation, serotonin-selective reuptake inhibitors (e.g., escitalopram) are preferred.
Citation	Teixeira AL, Kim Y, Cordeiro TM, de Erausquin GA, Rocha NP. Agitation in Alzheimer’s disease: From assessment to therapeutics. World J Psychiatry 2025; In press

Received	2025-05-15 01:49
Peer-Review Started	2025-05-26 00:08
To Make the First Decision
Return for Revision	2025-05-29 08:16
Revised	2025-06-09 20:08
Second Decision	2025-09-22 02:41
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2025-09-22 09:32
Articles in Press	2025-09-22 09:32
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript

ISSN	2220-3206 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com